연구성과로 돌아가기
2021 연구자 정보 (137 / 1146)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Joo, Seung-Jae (Joo, SJ) |
제1저자 | 교신저자 |
Jeju Natl Univ, Dept Internal Med, Sch Med, Jeju, South Korea Jeju Natl Univ Hosp, Dept Internal Med, Jeju, South Korea |
|
0000-0002-4322-0703 Joo, Seung-Jae |
[JCR상위 4.8] Effect of beta-blocker therapy in patients with or without left ventricular systolic dysfunction after acute myocardial infarction | SCIE | 4.8 | CARDIAC & CARDIOVASCULAR SYSTEMS;PHARMACOLOGY & PHARMACY | sejjoo@jejunu.ac.kr; |
|
Kim, Beom Kyung (Kim, BK) |
Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea Yonsei Univ, Inst Gastroenterol, Dept Internal Med, Coll Med, Seoul, South Korea Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea Yonsei Univ Hlth Syst, Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea Yonsei Univ Hlth Syst, Severance Hosp, Yonsel Liver Ctr, Seoul, South Korea Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 120752, South Korea Yonsei Univ, Dept Internal Med, Coll Med, Seoul 03722, South Korea Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul 03722, South Korea Severance Hosp, Yonsei Liver Ctr, Seoul 03722, South Korea Yonsei Univ, Yonsei Liver Ctr, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea |
I-5501-2015 Kim, Kyung |
0000-0002-5363-2496 Kim, Beom Kyung |
[JCR상위 4.8] An episode of detectable serum hepatitis B virus-DNA level does not affect risk of hepatic decompensation among untreated compensated cirrhosis patient with viral load of <2, 000 IU/ml [JCR상위 27.6] Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients [JCR상위 59.7] External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals [JCR상위 14.8] The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus-related hepatocellular carcinoma [JCR상위 5.9] AN EXTERNAL VALIDATION OF FIBROSCAN-AST SCORE (FAST) FOR NON-INVASIVE IDENTIFICATION OF PATIENTS AT RISK OF PROGRESSIVE NON-ALCOHOLIC STEATOHEPATITIS [JCR상위 59.7] Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B [JCR상위 16.7] Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B [JCR상위 59.7] Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir [JCR상위 24.3] Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease [JCR상위 48.0] Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma [JCR상위 60.8] Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study |
SCIE | 4.8 |
GASTROENTEROLOGY & HEPATOLOGY MEDICINE, GENERAL & INTERNAL GASTROENTEROLOGY & HEPATOLOGY;INFECTIOUS DISEASES;VIROLOGY ONCOLOGY |
beomkkim@yuhs.ac; ksukorea@yuhs.ac; beomkkim@yuhs.ac;lorry-lee@yuhs.ac;sikarue@yuhs.ac;ksukorea@yuhs.ac;DRPJY@yuhs.ac; dh.sinn@samsung.com;ksukorea@yuhs.ac; beomkkim@yuhs.ac;psyoung0419@gmail.com; KSUKOREA@yuhs.ac; sikarue@yuhs.ac;sinndhn@hanmail.net;psyoung0419@gmail.com;HJSHIN105@yuhs.ac;lorry-lee@yuhs.ac;beomkkim@yuhs.ac;drpjy@yuhs.ac;dyk1025@yuhs.ac;ahnsh@yuhs.ac;mdflorence@yuhs.ac;ksukorea@yuhs.ac; |
||
|
Kim, Chong Jin (Kim, CJ) |
Kyunghee Univ Hosp Gangdong, Dept Internal Med, Seoul, South Korea |
AAY-6890-2021 Kim, Jin Sug |
|
[JCR상위 4.8] Effect of beta-blocker therapy in patients with or without left ventricular systolic dysfunction after acute myocardial infarction | SCIE | 4.8 | CARDIAC & CARDIOVASCULAR SYSTEMS;PHARMACOLOGY & PHARMACY | sejjoo@jejunu.ac.kr; | ||
|
Kim, Do Young (Kim, DY) |
Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea Kyungpook Natl Univ, Dept Polymer Sci & Engn, Daegu, South Korea Yonsei Univ, Inst Gastroenterol, Dept Internal Med, Coll Med, Seoul, South Korea Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea Yonsei Univ Hlth Syst, Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea Yonsei Univ Hlth Syst, Severance Hosp, Yonsel Liver Ctr, Seoul, South Korea Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 120752, South Korea Yonsei Univ, Dept Internal Med, Coll Med, Seoul 03722, South Korea Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul 03722, South Korea Severance Hosp, Yonsei Liver Ctr, Seoul 03722, South Korea Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Hematol Oncol, Sch Med, Busan, South Korea Pusan Natl Univ, Pusan Natl Univ Hosp, Biomed Res Inst, Dept Hematol Oncol,Sch Med, Busan, South Korea Yonsei Univ, Yonsei Liver Ctr, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea |
G-6633-2015 AAB-1459-2021 F-4608-2014 L-9791-2019 T-8521-2019 J-5387-2012 F-5424-2012 Kim, Yoon , Do Young Kim Kim, Dong Kim, Jung Kim, Young Kim, Nayoung Kim, Young Hoon |
0000-0003-4438-5443 0000-0002-8327-3439 0000-0002-9468-8939 Kim, Do Young |
[JCR상위 4.8] An episode of detectable serum hepatitis B virus-DNA level does not affect risk of hepatic decompensation among untreated compensated cirrhosis patient with viral load of <2, 000 IU/ml [JCR상위 21.7] Preparation Characterization of Modified Poly(Lactic Acid) Using Dicumyl Peroxide and Tetraglycidyl Diamino Diphenyl Methane [JCR상위 27.6] Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients [JCR상위 59.7] External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals [JCR상위 14.8] The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus-related hepatocellular carcinoma [JCR상위 5.9] AN EXTERNAL VALIDATION OF FIBROSCAN-AST SCORE (FAST) FOR NON-INVASIVE IDENTIFICATION OF PATIENTS AT RISK OF PROGRESSIVE NON-ALCOHOLIC STEATOHEPATITIS [JCR상위 59.7] Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B [JCR상위 16.7] Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B [JCR상위 59.7] Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir [JCR상위 24.3] Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease [JCR상위 48.0] Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma [JCR상위 13.7] Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and ¹⁸F-FDG PET/CT [JCR상위 1.9] Development of a New Risk Stratification System for Patients with Newly Diagnosed Multiple Myeloma Using R-ISS and 18F-FDG PET/CT [JCR상위 60.8] Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study |
SCIE | 1.9 |
GASTROENTEROLOGY & HEPATOLOGY ENGINEERING, ENVIRONMENTAL;POLYMER SCIENCE MEDICINE, GENERAL & INTERNAL GASTROENTEROLOGY & HEPATOLOGY;INFECTIOUS DISEASES;VIROLOGY ONCOLOGY HEMATOLOGY;ONCOLOGY HEMATOLOGY |
beomkkim@yuhs.ac; khseo@knu.ac.kr; ksukorea@yuhs.ac; beomkkim@yuhs.ac;lorry-lee@yuhs.ac;sikarue@yuhs.ac;ksukorea@yuhs.ac;DRPJY@yuhs.ac; dh.sinn@samsung.com;ksukorea@yuhs.ac; beomkkim@yuhs.ac;psyoung0419@gmail.com; KSUKOREA@yuhs.ac; sikarue@yuhs.ac;sinndhn@hanmail.net;psyoung0419@gmail.com;HJSHIN105@yuhs.ac;lorry-lee@yuhs.ac;beomkkim@yuhs.ac;drpjy@yuhs.ac;dyk1025@yuhs.ac;ahnsh@yuhs.ac;mdflorence@yuhs.ac;ksukorea@yuhs.ac; drjejung@chonnam.ac.kr;jhmoon@knu.ac.kr; |
||
|
Kim, Kyung Mo (Kim, KM) |
Asan Med Ctr Childrens Hosp, Ulsan Coll Med, Seoul, South Korea |
|
|
[JCR상위 4.8] Long-term Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Children with Chronic Hepatitis B (CHB): Final Results from a Placebo-Controlled Trial | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | john.flaherty@gilead.com; | ||
|
Kim, Seung Up (Kim, SU) |
Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea Yonsei Univ, Inst Gastroenterol, Dept Internal Med, Coll Med, Seoul, South Korea Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea Yonsei Univ Hlth Syst, Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea Yonsei Univ Hlth Syst, Severance Hosp, Yonsel Liver Ctr, Seoul, South Korea Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 120752, South Korea Yonsei Univ, Dept Internal Med, Coll Med, Seoul 03722, South Korea Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul 03722, South Korea Severance Hosp, Yonsei Liver Ctr, Seoul 03722, South Korea Yonsei Univ, Yonsei Liver Ctr, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea Yonsei Univ, Coll Med, Dept Internal Med, Severance Hosp, Seoul, South Korea Yonsei Univ, Coll Med, Yonsei Liver Ctr, Severance Hosp, Seoul, South Korea Yonsei Univ Hlth Syst, Severance Hosp, Seoul, South Korea |
L-4239-2013 AAM-7334-2020 J-5409-2012 ABF-3773-2021 Kim, Sun Kim, Sun Jung Kim, Sung-Won Kim, Heui-Soo |
0000-0002-9658-8050 Kim, Seung Up |
[JCR상위 4.8] An episode of detectable serum hepatitis B virus-DNA level does not affect risk of hepatic decompensation among untreated compensated cirrhosis patient with viral load of <2, 000 IU/ml [JCR상위 27.6] Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients [JCR상위 59.7] External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals [JCR상위 14.8] The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus-related hepatocellular carcinoma [JCR상위 5.9] AN EXTERNAL VALIDATION OF FIBROSCAN-AST SCORE (FAST) FOR NON-INVASIVE IDENTIFICATION OF PATIENTS AT RISK OF PROGRESSIVE NON-ALCOHOLIC STEATOHEPATITIS [JCR상위 59.7] Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B [JCR상위 16.7] Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B [JCR상위 59.7] Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir [JCR상위 24.3] Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease [JCR상위 48.0] Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma [JCR상위 60.8] Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study [JCR상위 4.8] The artificial intelligence-driven model for prediction of hepatocellular carcinoma development in chronic hepatitis B patients: Derivation and validation using 11, 111 patients from Asian and Caucasian cohorts [JCR상위 4.8] Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies [JCR상위 5.9] IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B |
SCIE | 4.8 |
GASTROENTEROLOGY & HEPATOLOGY MEDICINE, GENERAL & INTERNAL GASTROENTEROLOGY & HEPATOLOGY;INFECTIOUS DISEASES;VIROLOGY ONCOLOGY |
beomkkim@yuhs.ac; ksukorea@yuhs.ac; beomkkim@yuhs.ac;lorry-lee@yuhs.ac;sikarue@yuhs.ac;ksukorea@yuhs.ac;DRPJY@yuhs.ac; dh.sinn@samsung.com;ksukorea@yuhs.ac; beomkkim@yuhs.ac;psyoung0419@gmail.com; KSUKOREA@yuhs.ac; sikarue@yuhs.ac;sinndhn@hanmail.net;psyoung0419@gmail.com;HJSHIN105@yuhs.ac;lorry-lee@yuhs.ac;beomkkim@yuhs.ac;drpjy@yuhs.ac;dyk1025@yuhs.ac;ahnsh@yuhs.ac;mdflorence@yuhs.ac;ksukorea@yuhs.ac; pindra@empal.com; ychoi@cymabay.com; |
||
|
Kim, Song-Yi (Kim, SY) |
Jeju Natl Univ, Dept Internal Med, Sch Med, Jeju, South Korea Jeju Natl Univ Hosp, Dept Internal Med, Jeju, South Korea |
JAC-5358-2023 Kim, Song-Yi |
0000-0002-1170-8165 Kim, Song-Yi |
[JCR상위 4.8] Effect of beta-blocker therapy in patients with or without left ventricular systolic dysfunction after acute myocardial infarction | SCIE | 4.8 | CARDIAC & CARDIOVASCULAR SYSTEMS;PHARMACOLOGY & PHARMACY | sejjoo@jejunu.ac.kr; | ||
|
Kim, Won (Kim, W) |
Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Seoul, South Korea Seoul Natl Univ, Seoul Metropolitan Govt, Dept Internal Med, Boramae Med Ctr,Coll Med, Seoul, South Korea |
H-6940-2019 Kim, Won |
|
[JCR상위 4.8] Safety, efficacy, and pharmacodynamic (PD) activity of 12 weeks treatment with oral RIG-I agonist, inarigivir (IRIG), plus 48 weeks of tenofovir alafenamide in adult patients with chronic hepatitis B: a phase 2 collaboration study [JCR상위 19.9] Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial |
SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY |
jenny.yang@gilead.com; umsh@korea.ac.kr; |
||
|
Lake, John (Lake, J) |
Univ Minnesota, Minneapolis, MN USA |
|
|
[JCR상위 4.8] Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | ychoi@cymabay.com; | ||
|
Lampertico, Pietro (Lampertico, P) |
Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, CRC AM & A Migliavacca Ctr Liver Dis, Milan, Italy Univ Milan, Fdn Irccs Ca Granda Osped Maggiore Policlin, CRC AM & A Migliavacca Ctr Liver Dis, Milan, Italy |
J-8463-2018 Lampertico, Pietro |
|
[JCR상위 4.8] The artificial intelligence-driven model for prediction of hepatocellular carcinoma development in chronic hepatitis B patients: Derivation and validation using 11, 111 patients from Asian and Caucasian cohorts [JCR상위 5.9] IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B |
SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | pindra@empal.com; | ||
|
Lee, Hye Won (Lee, HW) |
제1저자 |
Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea Keimyung Univ, Sch Med, Dept Pathol, Daegu, South Korea Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea Yonsei Univ Hlth Syst, Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea Keimyung Univ, Dept Pathol, Sch Med, Daegu, South Korea Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea Yonsei Univ Hlth Syst, Severance Hosp, Yonsel Liver Ctr, Seoul, South Korea Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea Keimyung Univ, Sch Med, Dept Pathol, 1035 Dalgubeol Daero, Daegu 42601, South Korea Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 120752, South Korea Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea Yonsei Univ, Dept Internal Med, Coll Med, Seoul 03722, South Korea Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul 03722, South Korea Severance Hosp, Yonsei Liver Ctr, Seoul 03722, South Korea |
D-9081-2016 Lee, Hye |
0000-0001-8540-524X 0000-0002-3552-3560 Lee, Hye Won |
[JCR상위 4.8] An episode of detectable serum hepatitis B virus-DNA level does not affect risk of hepatic decompensation among untreated compensated cirrhosis patient with viral load of <2, 000 IU/ml [JCR상위 71.2] Long interspersed nuclear element-1 hypomethylation is associated with poor outcomes via the activation of ST18 in human hepatocellular carcinoma [JCR상위 59.7] External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals [JCR상위 5.9] CIRCULAR NONCODING RNA HSACIRC₀₀₀₅₉₈₆ AS A PROGNOSTIC BIOMARKER FOR HEPATOCELLULAR CARCINOMA [JCR상위 5.9] CIRCULATING EXOSOMAL LNCRNA-ATB PROMOTES MYOPENIA IN HUMAN HEPATOCELLULAR CARCINOMA [JCR상위 5.9] AN EXTERNAL VALIDATION OF FIBROSCAN-AST SCORE (FAST) FOR NON-INVASIVE IDENTIFICATION OF PATIENTS AT RISK OF PROGRESSIVE NON-ALCOHOLIC STEATOHEPATITIS [JCR상위 59.7] Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B [JCR상위 16.7] Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B [JCR상위 25.0] Circular noncoding RNA hsacᵢᵣc₀₀₀₅₉₈₆ as a prognostic biomarker for hepatocellular carcinoma [JCR상위 59.7] Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir [JCR상위 24.3] Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease |
SCIE | 4.8 |
GASTROENTEROLOGY & HEPATOLOGY MEDICINE, GENERAL & INTERNAL GASTROENTEROLOGY & HEPATOLOGY;INFECTIOUS DISEASES;VIROLOGY MULTIDISCIPLINARY SCIENCES ONCOLOGY |
beomkkim@yuhs.ac; KeunHur@knu.ac.kr; beomkkim@yuhs.ac;lorry-lee@yuhs.ac;sikarue@yuhs.ac;ksukorea@yuhs.ac;DRPJY@yuhs.ac; beomkkim@yuhs.ac;psyoung0419@gmail.com; magnolia1103@naver.com;KeunHur@knu.ac.kr; KSUKOREA@yuhs.ac; sikarue@yuhs.ac;sinndhn@hanmail.net;psyoung0419@gmail.com;HJSHIN105@yuhs.ac;lorry-lee@yuhs.ac;beomkkim@yuhs.ac;drpjy@yuhs.ac;dyk1025@yuhs.ac;ahnsh@yuhs.ac;mdflorence@yuhs.ac;ksukorea@yuhs.ac; |
|
|
Lee, Hyung-Chul (Lee, HC) |
Seoul Natl Univ, Dept Anesthesiol, Coll Med, Seoul, South Korea |
U-1910-2019 Lee, Hyung-Chul |
|
[JCR상위 4.8] The artificial intelligence-driven model for prediction of hepatocellular carcinoma development in chronic hepatitis B patients: Derivation and validation using 11, 111 patients from Asian and Caucasian cohorts | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | pindra@empal.com; | ||
|
Lee, Jae Seung (Lee, JS) |
Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea Yonsei Univ Hlth Syst, Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea Yonsei Univ Hlth Syst, Severance Hosp, Yonsel Liver Ctr, Seoul, South Korea Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 120752, South Korea Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea Yonsei Univ, Dept Internal Med, Coll Med, Seoul 03722, South Korea Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul 03722, South Korea Severance Hosp, Yonsei Liver Ctr, Seoul 03722, South Korea |
KHT-9575-2024 LEE, JAE SEUNG |
0000-0002-2371-0967 Lee, Jae Seung |
[JCR상위 4.8] An episode of detectable serum hepatitis B virus-DNA level does not affect risk of hepatic decompensation among untreated compensated cirrhosis patient with viral load of <2, 000 IU/ml [JCR상위 59.7] External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals [JCR상위 5.9] AN EXTERNAL VALIDATION OF FIBROSCAN-AST SCORE (FAST) FOR NON-INVASIVE IDENTIFICATION OF PATIENTS AT RISK OF PROGRESSIVE NON-ALCOHOLIC STEATOHEPATITIS [JCR상위 59.7] Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B [JCR상위 16.7] Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B [JCR상위 59.7] Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir [JCR상위 24.3] Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease [JCR상위 48.0] Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma |
SCIE | 4.8 |
GASTROENTEROLOGY & HEPATOLOGY GASTROENTEROLOGY & HEPATOLOGY;INFECTIOUS DISEASES;VIROLOGY ONCOLOGY MEDICINE, GENERAL & INTERNAL |
beomkkim@yuhs.ac; beomkkim@yuhs.ac;lorry-lee@yuhs.ac;sikarue@yuhs.ac;ksukorea@yuhs.ac;DRPJY@yuhs.ac; beomkkim@yuhs.ac;psyoung0419@gmail.com; KSUKOREA@yuhs.ac; sikarue@yuhs.ac;sinndhn@hanmail.net;psyoung0419@gmail.com;HJSHIN105@yuhs.ac;lorry-lee@yuhs.ac;beomkkim@yuhs.ac;drpjy@yuhs.ac;dyk1025@yuhs.ac;ahnsh@yuhs.ac;mdflorence@yuhs.ac;ksukorea@yuhs.ac; dh.sinn@samsung.com;ksukorea@yuhs.ac; |
||
|
Lee, Jae-Geun (Lee, JG) |
Jeju Natl Univ Hosp, Dept Internal Med, Jeju, South Korea |
KHT-2438-2024 Lee, Jungmin |
0000-0003-4915-9584 Lee, Jae-Geun |
[JCR상위 4.8] Effect of beta-blocker therapy in patients with or without left ventricular systolic dysfunction after acute myocardial infarction | SCIE | 4.8 | CARDIAC & CARDIOVASCULAR SYSTEMS;PHARMACOLOGY & PHARMACY | sejjoo@jejunu.ac.kr; | ||
|
Lee, Jeonghoon (Lee, J) |
Seoul Natl Univ Hosp, Seoul, South Korea Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea |
Q-1055-2018 Lee, Jeong-Hoon |
|
[JCR상위 4.8] ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH [JCR상위 4.8] The artificial intelligence-driven model for prediction of hepatocellular carcinoma development in chronic hepatitis B patients: Derivation and validation using 11, 111 patients from Asian and Caucasian cohorts |
SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY |
jhamilton@arrowheadpharma.com; pindra@empal.com; |
페이지 이동: